Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study - Bokemeyer, C; Bondarenko, I; Makhson, A (Journal of Clinical Oncology, 2007)
ASCO Annual Meeting Proceedings Part I 2007